| Assessing the global threat from Zika virus J Lessler, LH Chaisson, LM Kucirka, Q Bi, K Grantz, H Salje, AC Carcelen, ... Science 353 (6300), 2016 | 297 | 2016 |
| Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment NM Ferguson, I Rodríguez-Barraquer, I Dorigatti, L Mier-y-Teran-Romero, ... Science 353 (6303), 1033-1036, 2016 | 186 | 2016 |
| A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease AT Huang, B Garcia-Carreras, MDT Hitchings, B Yang, LC Katzelnick, ... MedRxiv, 2020 | 165 | 2020 |
| From re-emergence to hyperendemicity: the natural history of the dengue epidemic in Brazil I Rodriguez-Barraquer, MT Cordeiro, C Braga, WV de Souza, ET Marques, ... PLoS neglected tropical diseases 5 (1), e935, 2011 | 157 | 2011 |
| The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia): a model comparison study S Flasche, M Jit, I Rodríguez-Barraquer, L Coudeville, M Recker, K Koelle, ... PLoS medicine 13 (11), e1002181, 2016 | 151 | 2016 |
| Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region I Rodriguez-Barraquer, F Costa, EJM Nascimento, N Nery, PMS Castanha, ... Science 363 (6427), 607-610, 2019 | 120 | 2019 |
| Reconstruction of antibody dynamics and infection histories to evaluate dengue risk H Salje, DAT Cummings, I Rodriguez-Barraquer, LC Katzelnick, J Lessler, ... Nature 557 (7707), 719-723, 2018 | 105 | 2018 |
| A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity AT Huang, B Garcia-Carreras, MDT Hitchings, B Yang, LC Katzelnick, ... Nature communications 11 (1), 1-16, 2020 | 101 | 2020 |
| Enhancing disease surveillance with novel data streams: challenges and opportunities BM Althouse, SV Scarpino, LA Meyers, JW Ayers, M Bargsten, ... EPJ Data Science 4 (1), 1-8, 2015 | 91 | 2015 |
| Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children LC Rubiano, MIC Miranda, S Muvdi Arenas, LM Montero, ... Journal of Infectious Diseases 205 (4), 684-692, 2012 | 89 | 2012 |
| Unraveling the drivers of MERS-CoV transmission S Cauchemez, P Nouvellet, A Cori, T Jombart, T Garske, H Clapham, ... Proceedings of the national academy of sciences 113 (32), 9081-9086, 2016 | 81 | 2016 |
| Serology for SARS-CoV-2: apprehensions, opportunities, and the path forward JE Bryant, AS Azman, MJ Ferrari, BF Arnold, MF Boni, Y Boum, K Hayford, ... Science Immunology 5 (47), 2020 | 71 | 2020 |
| Revisiting Rayong: shifting seroprofiles of dengue in Thailand and their implications for transmission and control I Rodríguez-Barraquer, R Buathong, S Iamsirithaworn, A Nisalak, ... American journal of epidemiology 179 (3), 353-360, 2014 | 70 | 2014 |
| The hidden burden of dengue and chikungunya in Chennai, India I Rodríguez-Barraquer, SS Solomon, P Kuganantham, AK Srikrishnan, ... PLoS neglected tropical diseases 9 (7), e0003906, 2015 | 62 | 2015 |
| Reconstruction of 60 years of chikungunya epidemiology in the Philippines demonstrates episodic and focal transmission H Salje, S Cauchemez, MT Alera, I Rodriguez-Barraquer, ... The Journal of infectious diseases 213 (4), 604-610, 2015 | 58 | 2015 |
| Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia OL Fernández, Y Diaz-Toro, C Ovalle, L Valderrama, S Muvdi, ... PLoS Negl Trop Dis 8 (5), e2871, 2014 | 56 | 2014 |
| Etiologic agent of an epidemic of cutaneous leishmaniasis in Tolima, Colombia I Rodríguez-Barraquer, R Góngora, M Prager, R Pacheco, LM Montero, ... The American journal of tropical medicine and hygiene 78 (2), 276-282, 2008 | 55 | 2008 |
| Immune correlates of protection for dengue: state of the art and research agenda LC Katzelnick, E Harris, R Baric, BA Coller, J Coloma, JE Crowe Jr, ... Vaccine 35 (36), 4659-4669, 2017 | 53 | 2017 |
| Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis K Rainwater-Lovett, I Rodriguez-Barraquer, DAT Cummings, J Lessler BMC infectious diseases 12 (1), 1-15, 2012 | 53 | 2012 |
| Potential opportunities and perils of imperfect dengue vaccines I Rodriguez-Barraquer, L Mier-y-Teran-Romero, IB Schwartz, DS Burke, ... Vaccine 32 (4), 514-520, 2014 | 44 | 2014 |
Derek A.T. CummingsProfessor, Dept. of Biology, Univ. of Florida and Adj. Professor, Dept. of Epidemiology, JHBSPHufl.edu üzerinde doğrulanmış e-posta adresine sahip
